GLOMERULONEPHRITIS
Clinical trials for GLOMERULONEPHRITIS explained in plain language.
Never miss a new study
Get alerted when new GLOMERULONEPHRITIS trials appear
Sign up with your email to follow new studies for GLOMERULONEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes drug tame the immune system in kidney disease?
Disease control Not yet recruitingThis phase 2 trial tests whether dapagliflozin, a drug used for diabetes and heart failure, can reduce harmful antibodies and prevent relapses in people with membranous nephropathy, an autoimmune kidney disease. The study enrolls 20 adults who have had a recent rise in anti-PLA2R…
Matched conditions: GLOMERULONEPHRITIS
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Computer alert aims to catch kidney disease early
Knowledge-focused Not yet recruitingThis study tests whether an electronic health record alert can help primary care doctors refer patients with blood and protein in their urine to a kidney specialist. About 1,200 adults with these high-risk signs will be included. The goal is to see if the alert improves referral …
Matched conditions: GLOMERULONEPHRITIS
Phase: NA • Sponsor: Geisinger Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC